Join the Hypertension group to help and get support from people like you.
Hypertension News (Page 9)
FDA Medwatch Alert: Labetalol Hydrochloride Injection 100 MG/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira: Recall - Visible Particulates
ISSUE: Hospira, Inc. will initiate a voluntary nationwide recall to the user level for one lot of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL) 20 mL Multidose Vial, NDC...
FDA Medwatch Alert: Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like...
FDA Medwatch Alert: Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
including: Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) Tekturna (aliskiren hemifumarate) Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tekamlo...
FDA Approves Edarbyclor (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
DEERFIELD, Ill. and OSAKA, Japan, Dec. 20, 2011 /PRNewswire/ – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced...
FDA Approves Edarbi to Treat High Blood Pressure
ROCKVILLE, MD., Feb. 25, 2011--The U.S. Food and Drug Administration today approved Edarbi tablets (azilsartan medoxomil) to treat high blood pressure (hypertension) in adults. Data from clinical...
Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
EAST HANOVER, N.J., December 22, 2010, 2010 /PRNewswire/ – Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide)...
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
EAST HANOVER, N.J., Aug. 27 /PRNewswire/ – The US Food and Drug Administration (FDA) approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure...
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
PARSIPPANY, N.J., July 26 /PRNewswire/ – Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Tribenzor (olmesartan medoxomil, amlodipine,...
FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension
FDA Approves New Use for Micardis in Cardiovascular Risk Reduction and Twynsta as New Combination Treatment for High Blood Pressure Ridgefield, CT, October 19, 2009 - Boehringer Ingelheim...
Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Basel, September 17, 2009 - The US Food and Drug Administration (FDA) has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Cardiovascular Conditions and Disorders
Related drug support groups
lisinopril, metoprolol, amlodipine, propranolol, losartan, atenolol, hydrochlorothiazide, spironolactone, clonidine, view more... carvedilol, Metoprolol Succinate ER, Bystolic, diltiazem, Lasix, Metoprolol Tartrate, furosemide, bisoprolol, valsartan, Norvasc, ramipril, prazosin, guanfacine, Benicar, Coreg, Diovan, verapamil, nitroglycerin